Evidence map›Paper›PMID 38097184›Full record

ArticleThe Journal of biological chemistry2024

A rapid, tag-free way to purify functional GPCRs.

Anthony D Shumate, David L Farrens

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Nano-GAngewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anthony D ShumateDepartment of Chemical Biology and Physiology, Oregon Health and Science University, Portland, Oregon, USA.
David L FarrensDepartment of Chemical Biology and Physiology, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: farrensd@ohsu.edu.

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KIRSTEN Jeanne LAMPI · 1995 to 2026
$19.4M
BIOLOGICAL BASES OF DRUG-SEEKING BEHAVIORT32DA007262 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WILLIAMS, JOHN T · 1991 to 2022
$9.4M
Structural Dynamics in Rhodopsin Activation and AttenuationR01EY029343 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI David L Farrens · 2019 to 2026
$2.9M
Orbitrap Tribrid Mass SpectrometerS10OD028533 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVID, LARRY L · 2021 to 2021
$1.1M
Crystallization and Structural Analysis of the Human Cannabinoid Receptor CB1R21DA043001 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI FARRENS, DAVID L · 2017 to 2018
$424k
Identifying Dynamic Equilibrium Binding of Retinal and Non-retinal Ligands to RhodopsinR21EY027959 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI FARRENS, DAVID L · 2017 to 2018
$424k
An investigation of the mechanisms governing allosterism and G-protein selectivity of the human cannabinoid receptor, CB1.    F31DA049438 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI SHUMATE, ANTHONY D · 2019 to 2021
$137k
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY029343NEI NIH HHS R21 EY027959NIDA NIH HHS F31 DA049438NIDA NIH HHS R21 DA043001NIDA NIH HHS T32 DA007262NIH HHS S10 OD028533
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) play diverse signaling roles and represent major pharmaceutical targets. Consequently, they are the focus of intense study, and numerous advances have been made in their handling and analysis. However, a universal way to purify GPCRs has remained elusive, in part because of their inherent instability when isolated from cells. To address this, we have developed a general, rapid, and tag-free way to purify GPCRs. The method uses short peptide analogs of the Gα subunit C terminus (Gα-CT) that are attached to chromatography beads (Gα-CT resin). Because the Gα-CT peptides bind active GPCRs with high affinity, the Gα-CT resin selectively purifies only active functional receptors. We use this method to purify both rhodopsin and the β

Indexed as

Receptors, G-Protein-CoupledSignal TransductionRhodopsinReceptors, G-Protein-CoupledRhodopsinaffinity chromatographyG protein–coupled receptorligand-binding proteinmembrane proteinprotein purification

Identifiers

PMID38097184
PMCPMC10820827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.